Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 2Motor Activity 1Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Health Surveys × 90 days × Clear all
NCT06773897 2026-05-22

RUGCC-BC

Rutgers, The State University of New Jersey

Recruiting
25,000 enrolled
Breast

Breast Neoplasms

NCT06340503 2026-03-19

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

Wake Forest University Health Sciences

Phase NA Active not recruiting
20 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡